WHO ICTRP trial
A Study, in which patients with advanced hepatocellular carcinoma (HCC) and…
EUCTR2020-000775-20-DE · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2020-000775-20-DE |
|---|---|
| Public title | A Study, in which patients with advanced hepatocellular carcinoma (HCC) and preserved liver function are treated with a reduced starting dose of cabozantinib, followed by an increase of dose, after treatment failure of one previous therapy |
| Scientific title | A phase II study evaluating reduced starting dose and dose escalation of Cabozantinib as second-line therapy for advanced HCC in patients with preserved liver function |
| Primary sponsor | Frankfurter Institut für Klinische Krebsforschung IKF GmbH am Krankenhaus Nordwest |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Germany |
| Conditions | Advanced stage hepatocellular carcinoma (HCC) patients with preserved liver function in second line therapy;Therapeutic area: Diseases [C] - Cancer [C04] |
| Interventions | Trade Name: Cabometyx Product Name: Cabozantinib Pharmaceutical Form: Film-coated tablet INN or Proposed INN: Cabozantinib CAS Number: 1140909-48-3 Other descriptive name: Cabozantinib S-malate Concentration unit: mg milligram(s)… |
| Registration date | Apr 27, 2020 |
| Target size | 40 |
| Secondary IDs | CaboRISE |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: